IDEX (NYSE:IEX) Issues Q3 2026 Earnings Guidance

IDEX (NYSE:IEX) updated its third quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 2.200-2.250 for the period, compared to the consensus earnings per share estimate of 2.190. The company issued revenue guidance of -. IDEX also updated its FY 2026 guidance to 8.700-8.850 EPS.

IDEX Trading Up 2.5%

Shares of IDEX stock traded up $5.78 during trading hours on Thursday, hitting $235.30. The company’s stock had a trading volume of 787,933 shares, compared to its average volume of 774,792. The company has a market capitalization of $17.41 billion, a PE ratio of 34.81, a price-to-earnings-growth ratio of 2.21 and a beta of 0.98. IDEX has a 12 month low of $157.25 and a 12 month high of $243.80. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.39 and a quick ratio of 2.40. The stock has a 50 day moving average of $220.26 and a 200 day moving average of $208.04.

IDEX (NYSE:IEX) last posted its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.11 by $0.21. IDEX had a return on equity of 15.29% and a net margin of 14.38%.The business had revenue of $920.60 million during the quarter, compared to the consensus estimate of $905.38 million. During the same period last year, the company earned $2.07 earnings per share. IDEX’s quarterly revenue was up 6.4% on a year-over-year basis. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. Analysts predict that IDEX will post 8.48 earnings per share for the current year.

IDEX Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were paid a dividend of $0.73 per share. The ex-dividend date was Monday, July 6th. This represents a $2.92 annualized dividend and a dividend yield of 1.2%. IDEX’s payout ratio is currently 43.20%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Oppenheimer reiterated an “outperform” rating and set a $265.00 price target on shares of IDEX in a report on Thursday. Royal Bank Of Canada boosted their target price on IDEX from $252.00 to $261.00 and gave the stock an “outperform” rating in a report on Thursday, July 16th. Weiss Ratings upgraded IDEX from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, June 24th. Citigroup reissued a “buy” rating on shares of IDEX in a research report on Thursday. Finally, Robert W. Baird set a $257.00 price objective on shares of IDEX in a research note on Thursday, April 30th. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, IDEX presently has an average rating of “Moderate Buy” and an average price target of $247.44.

Insider Activity

In related news, CEO Eric D. Ashleman sold 15,385 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $215.22, for a total value of $3,311,159.70. Following the transaction, the chief executive officer owned 66,658 shares in the company, valued at approximately $14,346,134.76. This trade represents a 18.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.50% of the company’s stock.

IDEX News Summary

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Quarterly results exceeded expectations. IDEX reported adjusted earnings of $2.32 per share versus the $2.11 analyst consensus, while revenue rose 6.4% year over year to $920.6 million, topping estimates of approximately $905.4 million. IDEX Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Orders signaled strong forward demand. Record orders of roughly $1.07 billion increased 29% reported and 28% organically. Management highlighted momentum in its Health & Science Technologies business, including demand related to AI data centers and semiconductor manufacturing. IDEX rises after Q2 earnings beat and guidance hike
• Positive Sentiment: Full-year guidance was raised. IDEX now expects 2026 organic sales growth of 5% to 6% and adjusted diluted EPS of $8.70 to $8.85, above its previous $8.35 to $8.55 range and higher than the roughly $8.49 consensus. Third-quarter EPS guidance of $2.20 to $2.25 also edged above estimates. IDEX lifts annual profit outlook
• Positive Sentiment: TD Cowen became more bullish. The firm raised its IDEX price target from $260 to $275 and upgraded the stock to “Buy,” citing an implied upside of approximately 17% from the referenced price.
• Neutral Sentiment: IDEX returned $131 million to shareholders during the quarter through $77 million of share repurchases and $54 million in dividends.
• Negative Sentiment: Recent insider activity remains a potential overhang: CEO Eric Ashleman reportedly made two open-market sales totaling 15,385 shares over the past six months, with no reported purchases. These transactions predate the latest earnings release and may not reflect management’s current outlook.

Institutional Trading of IDEX

Several institutional investors and hedge funds have recently modified their holdings of the business. CYBER HORNET ETFs LLC bought a new stake in IDEX during the 2nd quarter worth $35,000. MUFG Securities EMEA plc bought a new position in IDEX in the second quarter valued at about $39,000. McMillan Office Inc. acquired a new stake in shares of IDEX during the fourth quarter valued at about $46,000. Los Angeles Capital Management LLC bought a new stake in shares of IDEX during the fourth quarter worth about $57,000. Finally, Employees Retirement System of Texas bought a new stake in shares of IDEX during the third quarter worth about $99,000. 97.96% of the stock is currently owned by institutional investors.

About IDEX

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.